NEW YORK, July 24, 2013 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq: NDAQ ) announced that trading of Agios Pharmaceuticals, Inc. (Nasdaq: AGIO ), a biopharmaceutical company dedicated to developing innovative small molecule treatments for cancer and inborn errors of metabolism, commenced on The NASDAQ Stock Market on July 24, 2013.
Agios Pharmaceuticals, Inc. is a biopharmaceutical company passionately committed to applying its scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and inborn errors of metabolism, or IEMs, which are a subset of orphan genetic metabolic diseases. Agios Pharmaceuticals, Inc. uses cellular metabolism as a platform for developing potentially transformative medicines.
"Agios Pharmaceuticals, Inc. is a cutting edge biopharmaceutical company with the potential to change treatment for cancer and IEMs," said Nelson Griggs, Senior Vice President, NASDAQ OMX Corporate Client Group. "NASDAQ OMX is proud to welcome Agios Pharmaceuticals, Inc. to the NASDAQ OMX family."
NASDAQ OMX has been the exchange of choice for pioneering biopharmaceutical companies like Agios Pharmaceuticals, Inc. More than 90 percent of heath care companies that have listed on U.S. markets have chosen to call NASDAQ OMX home year-to-date in 2013.
About NASDAQ OMX Group :
The inventor of the electronic exchange, The NASDAQ OMX Group, Inc., fuels economies and provides transformative technologies for the entire lifecycle of a trade - from risk management to trade to surveillance to clearing. In the U.S. and Europe, we own and operate 26 markets, 3 clearinghouses and 5 central securities depositories supporting equities, options, fixed income, derivatives, commodities, futures and structured products. Able to process more than 1 million messages per second at sub-40 microsecond speeds with 99.99% uptime, our technology drives more than 70 marketplaces in 50 developed and emerging countries into the future, powering 1 in 10 of the world's securities transactions. Our award-winning data products and worldwide indexes are the benchmarks in the financial industry. Home to approximately 3,400 listed companies worth $6 trillion in market cap whose innovations shape our world, we give the ideas of tomorrow access to capital today. Welcome to where the world takes a big leap forward, daily. Welcome to the NASDAQ OMX Century. To learn more, visit nasdaqomx.com . Follow us on Facebook ( http://www.facebook.com/NASDAQ ) and Twitter ( http://www.twitter.com/nasdaqomx ). (Symbol: NDAQ and member of S&P 500)
The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. Neither The NASDAQ OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Statements regarding NASDAQ-listed companies are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.
-NDAQG -
NASDAQ OMX Media Contact: Joe Christinat (646) 441-5121
